You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 7,875,630


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,875,630 protect, and when does it expire?

Patent 7,875,630 protects ALTABAX and is included in one NDA.

This patent has thirteen patent family members in six countries.

Summary for Patent: 7,875,630
Title:Process salts compositions and use
Abstract:The present invention provides a novel process for preparing pleuromutilin derivatives, novel salts of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or solvates thereof, novel pharmaceutical compositions or formulations for topical administration comprising mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or a pharmaceutically acceptable salt or solvate thereof and their use in medical therapy, particularly antibacterial therapy.
Inventor(s): Breen; Gary Francis (Tonbridge, GB), Forth; Michael Anthony (Tonbridge, GB), Kopelman; Susan ShuMei Hu (King of Prussia, PA), Muller; Francis Xavier (King of Prussia, PA), Sanderson; Francis Dominic (Harlow, GB)
Assignee: Glaxo Group Limited (Greenford Middlesex, unknown)
Application Number:10/570,410
Patent Claim Types:
see list of patent claims
Compound; Process; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,875,630

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 7,875,630, exploring its claims, the patent's position within the broader patent landscape, and relevant legal and practical considerations.

Patent Overview

United States Patent 7,875,630, hereafter referred to as the '630 patent, is a utility patent granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its key components:

Inventors and Assignees

Identifying the inventors and assignees is essential for understanding the patent's ownership and potential licensing or litigation issues. This information can be found in the patent's front page or through the USPTO's patent search tools[4].

Claims

The claims section of a patent defines the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with dependent claims building upon independent claims. Each claim must be presumed valid independently of the others, as per 35 USC 282[5].

Claim Analysis

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are critical as they set the broadest scope of protection for the invention.

Dependent Claims

Dependent claims refer back to and further limit the independent claims. They often provide additional details or specific embodiments of the invention.

Patent Scope and Coverage

Background and Summary

The background and summary sections provide context for the invention, including prior art and the problems the invention solves. This helps in understanding the patent's position within the existing technological landscape.

Detailed Description

The detailed description section includes detailed explanations of the invention, often with drawings and diagrams. This section is crucial for understanding how the invention works and its various embodiments.

Patent Landscape

Prior Art and Citations

Understanding the prior art cited in the patent and any citations received by the patent can help in assessing its novelty and non-obviousness. Tools like the Common Citation Document (CCD) can consolidate citation data from multiple patent offices[4].

Patent Family

Identifying the patent family, which includes continuations, continuations-in-part, and divisions, is important. This can reveal how the patent fits into a broader series of related inventions and potential issues like obviousness-type double patenting (ODP)[1].

Legal Considerations

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue, especially if the patent is part of a family with multiple members. The Federal Circuit has ruled that ODP analysis must be performed to prevent an inventor from securing a second, later-expiring patent for the same invention[1].

Patent Term Adjustment (PTA) and Terminal Disclaimers

PTA and terminal disclaimers can affect the patent term. The Board has determined that a grant of PTA does not extend the term past the date of a terminal disclaimer, which is often used to overcome ODP rejections[1].

Practical Considerations

Search and Examination

Conducting a thorough search using tools like the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) can help identify potential prior art and related patents[4].

Litigation and Enforcement

Understanding the patent's validity and scope is crucial for litigation and enforcement. The presumption of validity under 35 USC 282 means that each claim is presumed valid unless proven otherwise[5].

Economic and Strategic Impact

Market Position

The '630 patent's position in the market can be assessed by analyzing its claims and the competitive landscape. This involves identifying potential infringers and competitors.

Licensing and Collaboration

The patent's scope and claims can also influence licensing agreements and collaborative efforts. A clear understanding of what is protected can facilitate negotiations and partnerships.

Data and Statistics

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into claim-level statistics and document-level statistics, which can help in understanding the broader trends in patenting within the relevant technological field[3].

Expert Insights

Legal and Academic Perspectives

Experts in intellectual property law, such as those involved in the ACUS study on a small claims patent court, can offer valuable insights into the legal and practical implications of the patent's claims and scope[2].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of protection.
  • Patent Landscape: Identifying the patent family and prior art is essential for assessing novelty and non-obviousness.
  • Legal Considerations: ODP, PTA, and terminal disclaimers can significantly impact the patent term and validity.
  • Practical Considerations: Thorough search and examination processes are vital for identifying potential issues.
  • Economic and Strategic Impact: The patent's market position and licensing potential depend on its claims and scope.

FAQs

  1. What is the significance of independent claims in a patent? Independent claims define the broadest scope of protection for the invention and stand alone without reference to other claims.

  2. How does obviousness-type double patenting (ODP) affect patents? ODP prevents an inventor from securing a second, later-expiring patent for the same invention, ensuring that patents do not extend beyond their intended term due to multiple filings.

  3. What is the role of the Patent Claims Research Dataset in patent analysis? The dataset provides detailed information on claims from US patents, including claim-level and document-level statistics, which can help in understanding trends and scope within a technological field.

  4. Why is it important to identify the patent family of a given patent? Identifying the patent family helps in understanding related inventions, potential issues like ODP, and the overall position of the patent within the broader patent landscape.

  5. How does the USPTO's Patent Public Search tool aid in patent analysis? The Patent Public Search tool provides enhanced access to prior art and related patents, improving the overall patent searching process and helping to identify potential issues and opportunities.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. 35 USC 282: Presumption of validity; defenses

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,875,630

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Almirall ALTABAX retapamulin OINTMENT;TOPICAL 022055-001 Apr 12, 2007 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,875,630

PCT Information
PCT FiledAugust 30, 2004PCT Application Number:PCT/US2004/028159
PCT Publication Date:March 17, 2005PCT Publication Number: WO2005/023257

International Family Members for US Patent 7,875,630

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 450535 ⤷  Subscribe
Germany 602004024417 ⤷  Subscribe
European Patent Office 1663220 ⤷  Subscribe
European Patent Office 2181995 ⤷  Subscribe
Spain 2335284 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.